Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Verus divests gastrointestinal program to Meritage Pharma
Included in the transaction are the rights to a novel formulation of an existing molecule intended to treat an emerging allergic inflammation condition of the gastrointestinal tract. Under
Included in the transaction are the rights to a novel formulation of an existing molecule intended to treat an emerging allergic inflammation condition of the gastrointestinal tract. Under
The company expects to grant the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock to cover over-allotments, if any. Luminex intends
The newly-launched studies will evaluate the organ protection potential of the first-in-class direct renin inhibitor Rasilez, known as Tekturna in the US, for the treatment of heart failure
Developed by CSL in collaboration with the Australian government, Panvax is intended for use in the prevention of influenza caused by a pandemic strain of avian influenza virus.
In this analysis, 120 patients had reached the 12-month, six treatment course (28 days on and 28 days off) study milestone, with 48 patients in the twice-daily group
Cymbalta (Duloxetine HCl) showed statistically significant improvement in pain associated with osteoarthritis of the knee according to the primary efficacy measure of mean 24-hour average pain scores. Approximately
Experiments conducted in triplicate have confirmed that COTI-2 has a profound effect on caspase-9 activation through inhibition of Akt/PKB. According to the company, the resulting activation of caspase-9
Results demonstrated that a once daily oral treatment of PBI-1402 induces a significant increase in hemoglobin level, red blood cell (RBC) count and hematocrit in chemotherapy-induced anemia (CIA)
This analysis evaluated a sub-group of patients (n=94) who were pre-selected to receive low dose Ara-C, a chemotherapy used in the treatment of myelodysplastic syndromes and acute myeloid
Quill SRS Monoderm, which is made from a rapidly resorbing polymer, is intended primarily for superficial wound closure applications and indicated for soft tissue approximation where use of